How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

About this item

Title

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

Content partner

Directory of Open Access Journals

Collection

Directory of Open Access Journals

Description

Abstract Background Germline BRCA1 and BRCA2 mutation testing offered shortly after a breast cancer diagnosis to inform women’s treatment choices - treatment-focused genetic testing ‘TFGT’ - has entered clinical practice in specialist centers and is likely to be soon commonplace in acute breast cancer management, especially for younger women. Yet the optimal way to deliver information about TFGT to younger women newly diagnosed with breast cancer is not known, particularly for those who were ...

Read more

Format

Research paper

Date created

2012-07-01

Creator

Watts Kaaren J / Meiser Bettina / Mitchell Gillian / Kirk Judy / Saunders Christobel / Peate Michelle / Duffy Jessica / Kelly Patrick J / Gleeson Margaret / Barlow-Stewart Kristine / Rahman Belinda / Friedlander Michael / Tucker Kathy

Contributing partner

BMC Cancer

URL

http://www.biomedcentral.com/1471-2407/12/320

Related subjects

Breast cancer / Genetic testing / BRCA1 / BRCA2 / Treatment / Clinical practice / Neoplasms / Tumors / Oncology / Including cancer and carcinogens

What is the copyright status of this item?

Share, Modify, Use commercially

See below for specifics about how you may use this item.

More Information

Directory of Open Access Journals has this to say about the rights status of this item:

CC BY (All metadata for this Directory of Open Access Journals record is available under the Creative Commons Attribution-ShareAlike License (CC BY-SA).)

You can learn more about the rights status of this item at: http://www.biomedcentral.com/about

What can I do with this item?

You must always check with Directory of Open Access Journals to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it

This item is suitable for copying and sharing with others, without further permission.

Modify it

This item is suitable for modifying, remixing and building upon, without further permission.

Use it commercially

This item is suitable for commercial use, without further permission.